Dual phases of apoptosis in pneumococcal meningitis

Lauren Mitchell1, S Hope Smith, Johann S Braun

  • 1Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 N. Lauderdale Road, Memphis, TN 38105, USA.

Insights

Bacterial meningitis causes neuronal apoptosis through two pathways. Early injury is independent of caspase-3, but later cell death is reduced without it, suggesting dual therapeutic targets for brain protection.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Bacterial meningitis causes significant neuronal injury, particularly in the hippocampus.
  • Apoptosis, involving caspase-dependent and independent pathways, contributes to pneumococcus-induced neuronal cell death.
  • The relative in vivo contributions of these apoptotic pathways remain unclear.

Purpose of the Study:

  • To investigate the role of caspase-dependent apoptosis in neuronal death during pneumococcal meningitis.
  • To differentiate the contributions of caspase-dependent and independent pathways to neuronal injury in vivo.

Main Methods:

  • Utilized mice deficient in caspase-3, ATM, and p53 activation.
  • Examined neuronal apoptosis at 18 and 24 hours post-infection with Streptococcus pneumoniae.
  • Assessed overall symptomatology and late sequelae of infection.

Main Results:

  • Neuronal injury at 18 hours post-infection was independent of the caspase-3 pathway.
  • Neuronal cell death at 24 hours post-infection was significantly attenuated in caspase-3 deficient mice.
  • Acute infection symptomatology was similar across all mouse groups, indicating late sequelae reflect neuronal death.

Conclusions:

  • Neuronal death in pneumococcal meningitis involves at least two distinct apoptotic mechanisms.
  • Early neuronal injury is caspase-3 independent, while later cell death is caspase-3 dependent.
  • Effective treatments for meningitis-induced neuronal damage must address both apoptotic pathways.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...